Practice Sales: Page 12

Drop in capital cost to bring windfall for practice valuation
By Thomas Climo, PhD
In his latest column, consultant Thomas Climo, PhD, measures how the drop in the cost of capital in 2015 could mean a significant windfall for dentists considering selling their practices.
February 4, 2015
2013 05 07 15 48 08 155 Climo Thomas 200
Henry Schein buys dental brokerage firm ADS Florida
By DrBicuspid.com staff writers
Henry Schein has acquired dental practice transition and brokerage company ADS Florida and its parent company, Professional Transitions.
January 12, 2015
Sirona gets 'buy' recommendation from brokerages
By DrBicuspid.com staff writers
Sirona Dental Systems has a "buy" recommendation from many ratings firms that are covering the stock, according to a report from the Analyst Ratings Network.
January 4, 2015
The valuation of trust: Part 2
By Thomas Climo, PhD
In part 2 of this series, consultant Thomas Climo, PhD, continues his discussion of trust in the process of buying and selling dental practices. Trust is established by accepting the valuation formula as calculated by an acceptable valuation professional and moving forward from there, he writes.
December 30, 2014
2013 05 07 15 48 08 155 Climo Thomas 200
The valuation of trust: Part 1
By Thomas Climo, PhD
As consultant Thomas Climo, PhD, writes, trust is an overarching topic that is too often not discussed. Why should a seller trust a buyer's agent, and why should a buyer trust a seller's broker? Until you answer this, the entire process of buying and selling dental practices may well be founded on miscommunication.
December 23, 2014
2013 05 07 15 48 08 155 Climo Thomas 200
Zimmer, European Commission extend review deadline for Biomet acquisition
By DrBicuspid.com staff writers
Zimmer Holdings announced that it has agreed with the European Commission (EC) to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a limited number of days to provide the EC with certain additional information.
November 18, 2014
Understanding practice valuation -- It's not just return on investment
By Mike Bark, CPA, CVA, MST, and Rob Joyce, MS
In this Second Opinion, certified public accountant and valuation analyst Mike Bark makes the case that dental brokers take many factors into consideration when coming to a valuation of a practice, including demographics, location, equipment, and more.
October 30, 2014
2013 12 23 15 23 25 385 Second Opinion 200
Do brokers prefer lower prices than owners? A research question
By Thomas Climo, PhD
In a new column separate from his latest series, consultant Thomas Climo, PhD, revisits the question of how do dental practice owners get the best price for their practice when they are considering selling. Looking at recent economic research, he urges dental practice owners to consider their options to get the best price.
October 9, 2014
2013 05 07 15 48 08 155 Climo Thomas 200
Buyer-driven transaction costs with no broker fees to sellers
By Thomas Climo, PhD
In his latest column, consultant Thomas Climo, PhD, discusses the idea recently presented to him of a 2% success fee for the sale of a dental practice, resulting in no broker fees for the seller. He writes that this 2% finder's fee is substantially below the commission rates being charged by brokers at present.
September 16, 2014
2013 05 07 15 48 08 155 Climo Thomas 200
Colgate kicks off Smile for Picture Day
By DrBicuspid.com staff writers
Colgate has partnered with actress, best-selling author, and education advocate Danica McKellar ("The Wonder Years," "Dancing with the Stars") as part of this year's Smile for Picture Day.
September 9, 2014
Dental brokers ought to go the way of travel agents
By Thomas Climo, PhD
In his latest column, Thomas Climo, PhD, makes the case that practice owners may be leaving money on the table when using a broker rather than an independent consultant when selling their practice. He explains why he believes dental brokers ought to go the way of travel agents.
September 3, 2014
2013 05 07 15 48 08 155 Climo Thomas 200
Biolase to raise $12M in private placement of stock
By DrBicuspid.com staff writers
Dental laser manufacturer Biolase has agreed to sell $12 million in unregistered shares of the company's common stock to institutional and individual investors in a private placement transaction.
July 20, 2014
Previous Page
Page 12 of 25
Next Page